Suppr超能文献

[微小RNA-216b通过靶向蛋白激酶Cα抑制鼻咽癌细胞的增殖和侵袭]

[miR-216b suppresses cell proliferation and invasion by targeting PKCα in nasopharyngeal carcinoma cells].

作者信息

Deng Min, Liu Ji-fang, Gu Yi-xue, Zheng Guo-pei, He Zhi-min

机构信息

Cancer Hospital and Cancer Research Institute, Guangzhou Medical University, Guangzhou 510095, China.

Cancer Hospital and Cancer Research Institute, Guangzhou Medical University, Guangzhou 510095, China. Email:

出版信息

Zhonghua Zhong Liu Za Zhi. 2013 Sep;35(9):645-50.

Abstract

OBJECTIVE

To elucidate whether miR-216b suppresses cell proliferation and invasion by targeting PKCα, thus to reveal the molecular mechanism that miR-216b functions as a tumor suppressor in nasopharyngeal carcinoma (NPC).

METHODS

PKCα 3'UTR-luciferase vector was constructed and dual-luciferase reporter gene assay was employed to examine the effect of miR-216b on luciferase activity. Nasopharyngeal cancer CNE2 cells were transfected with miR-216b mimics, and then qRT-PCR and Western blotting were performed to detect the expressions of PKCa mRNA and protein. The effects of PKCα downregulation on cell proliferation and invasion were assessed after PKCα siRNA were transfected into CNE2 cells. CNE2 cells were cotransfected with miR-216b mimics and PKCα plasmid, and the proliferation of CNE2 cells was assayed using a MTS cell proliferation assay kit.

RESULTS

The results of dual-luciferase reporter gene assay demonstrated that miR-216b could bind to the 3'-untranslated region (UTR) of PKCα and inhibited the luciferase activity to 62.4% of that of the mimics control cells. The expressions of PKCα mRNA and protein were significantly down-regulated by 49.1% and 55.7%, respectively, in comparison with that of the control cells. siRNA-mediated downregulation of PKCα suppressed the proliferation and invasion ability of CNE2 cells, and could partially mimic the tumor-inhibiting effect of miR-216b. Moreover, the overexpressed PKCα may partially reverse the inhibitory effect of miR-216b on proliferation of CNE2 cells.

CONCLUSION

miR-216b suppresses cell proliferation and invasion by targeting PKCα in NPC cells.

摘要

目的

阐明miR-216b是否通过靶向PKCα抑制细胞增殖和侵袭,从而揭示miR-216b在鼻咽癌(NPC)中发挥肿瘤抑制作用的分子机制。

方法

构建PKCα 3'UTR-荧光素酶载体,采用双荧光素酶报告基因检测法检测miR-216b对荧光素酶活性的影响。用miR-216b模拟物转染鼻咽癌CNE2细胞,然后进行qRT-PCR和蛋白质印迹法检测PKCa mRNA和蛋白质的表达。将PKCα siRNA转染到CNE2细胞中后,评估PKCα下调对细胞增殖和侵袭的影响。将miR-216b模拟物和PKCα质粒共转染CNE2细胞,使用MTS细胞增殖检测试剂盒检测CNE2细胞的增殖情况。

结果

双荧光素酶报告基因检测结果表明,miR-216b可与PKCα的3'-非翻译区(UTR)结合,并将荧光素酶活性抑制至模拟物对照细胞的62.4%。与对照细胞相比,PKCα mRNA和蛋白质的表达分别显著下调49.1%和55.7%。siRNA介导的PKCα下调抑制了CNE2细胞的增殖和侵袭能力,并可部分模拟miR-216b的肿瘤抑制作用。此外,过表达的PKCα可能部分逆转miR-216b对CNE2细胞增殖的抑制作用。

结论

miR-216b通过靶向NPC细胞中的PKCα抑制细胞增殖和侵袭。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验